News

PHARMADULE MORIMATSU INCREASE PRESENCE IN IRELAND

Pharmadule Morimatsu is proud to announce the opening of our new sales office in Dublin, Ireland. By establishing an office...

BIOLOGICALS & BIOSIMILARS MANUFACTURING FACILITY TO EGYPT

Pharmadule Morimatsu will deliver a modular turn-key facility to Egyptian International Pharmaceutical Industries, EIPICO,...

SHIPPING MODULAR VACCINE PLANT TO MOROCCO

Pharmadule Morimatsu has completed and shipped a turn-key modular vaccine facility to Morocco, Africa. The facility consists...

mRNA VACCINE PRODUCTION PLANT IN 7.5 MONTHS - MAKING A DIFFERENCE

Pharmadule Morimatsu has successfully completed the first SARS CoV-2 mRNA vaccine production plant to Chinese vaccine manufacturer...

PHARMADULE MORIMATSU EXPANDS - INTRODUCING MORIMATSU ITALY

Pharmadule Morimatsu expands the operation by opening an office in Milan, Italy. The Italian office will serve as a hub for...

MORIMATSU INTERNATIONAL OFFICIALLY LISTED ON THE HONG KONG STOCK EXCHANGE

On the afternoon of 28 June 2021, Morimatsu International Holdings Ltd. (hereinafter as “Morimatsu International”) was officially...

PHARMADULE MORIMATSU OPENS NEW OFFICE IN NEW JERSEY, USA

PHARMADULE MORIMATSU COMPLETED THE SETTING OF KUBIO MODULES FOR GE FIT-OUT OF THE LONZA BIOLOGICS FACILITY IN GUANGZHOU

On the December 12th 2019, with the last six modules being lift and placed within one day, 54 modules designed and fabricated...